# Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease

> **NCT02213224** · PHASE4 · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 180 (estimated)

## Conditions studied

- Nonalcoholic Fatty Liver Disease (NAFLD)

## Interventions

- **DRUG:** Perindopril
- **DRUG:** Telmisartan
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT02213224
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2016-09
- **Final completion:** 2017-09
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2014-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02213224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02213224, "Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02213224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*